Crescent Biopharma, Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-02 | NCT07909031 CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors | Phase 1/2 | Recruiting |
Active trials by phase
| Phase 1/2 | 2 |
Disease areas by active trials
Cervical Cancer (1) · Cholangiocarcinoma (1) · Endometrial Cancer (1) · Esophageal Cancer (1) · Head & Neck Cancer (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Ovarian Cancer (1)
Get alerts when Crescent Biopharma, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.